Managed Account Advisors’s Elevance Health ELV Stock Holding History

Managed Account Advisors’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	$91.6M	Sell	558,114 -54,847	-9%	-$8.76M	0.08%	281
2015 Q1	$94.6M	Sell	612,961 -19,998	-3%	-$2.85M	0.08%	269
2014 Q4	$79.5M	Sell	632,959 -161,679	-20%	-$20M	0.08%	295
2014 Q3	$95.1M	Sell	794,638 -7,600	-0.9%	-$872K	0.11%	231
2014 Q2	$86.3M	Sell	802,238 -16,917	-2%	-$1.74M	0.1%	229
2014 Q1	$81.5M	Buy	819,155 +571,039	+230%	+$51.6M	0.11%	232
2013 Q4	$22.9M	Sell	248,116 -33,119	-12%	-$2.94M	0.03%	599
2013 Q3	$23.5M	Sell	281,235 -36,031	-11%	-$3.09M	0.03%	542
2013 Q2	$26M	Buy	+317,266	New	+$23.7M	0.04%	472

Other funds holding ELV

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

GCM

Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return

Managed Account Advisors's ELV Position: Q2 2015 in Review

Managed Account Advisors reduced its Elevance Health (ELV) stake by 8.9% in Q2 2015, selling an estimated $8.76M and leaving 558,114 shares worth $91.6M. The position accounts for 0.08% of the portfolio, ranked #281.

Managed Account Advisors first reported a position in ELV in Q2 2013 and has held it in 9 quarters since. The position peaked at $95.1M in Q3 2014. 782 funds tracked by Wall St. Rank hold ELV as of Q2 2015.

Managed Account Advisors held 558,114 shares of Elevance Health worth $91.6M as of Q2 2015.
Managed Account Advisors sold 54,847 Elevance Health shares in Q2 2015, an estimated $8.76M.
Elevance Health made up 0.08% of Managed Account Advisors's portfolio in Q2 2015, its #281 holding.
Managed Account Advisors first reported a position in Elevance Health in Q2 2013 and has held it in 9 quarters since.
Managed Account Advisors's Elevance Health position peaked at $95.1M in Q3 2014.
782 funds tracked by Wall St. Rank held Elevance Health as of Q2 2015.

Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.